The Corporate Roots of the Opioid Crisis
Alternet
The ongoing and increasing revolving door phenomenon clearly suggests excess coziness between industry and government, now to the extent that industry and government leaders of health care are becoming interchangeable. true health care reform would cut the ties between government and corporate leaders.
Pharmaceutical companies spend billions of dollars marketing drugs to doctors. We have a few issues with that.
Not only do patents push higher prices onto consumers, they burden the research world with the increased costs of paying for the intellectual property needed to do further research . . . If anything, the neoliberal approach to academic research is a return to the privately funded, pre-tenure origins of the university system when numerous schools were simply research labs and promotional arms for private industry
Spread the word